Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biopharma/NIH 'PACT' Aims To Speed Cancer R&D

Executive Summary

A group of drug companies are collaborating with the National Institutes of Health and others in the Partnership for Accelerating Cancer Therapies in an effort to fund precompetitive cancer research, whose data will be shared broadly, with the aim of bringing more new therapies to patients in less time.


Related Content

FDA's Pazdur: I Won't Turn Into A Bureaucrat; My Presence Will Be Felt
FDA's Pazdur Jumps Over To New 'Moonshot' Role
Obama/Biden: Science Ready For Cancer 'Moon Shot'
US Capitol Capsule: Consortia tide rising: Does it float your boat?
Aligning cultures, putting skin in the game: Collins explains
NIH, 10 drug makers in $230m+ pact to attack Alzheimer's, other diseases


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts